To provide methods for treating diseases such as cancer and HIV infection, and methods of determining when a therapy to treat a disease characterized by production of regulator cells should be administered to a patient.

The method includes a process of monitoring patients or samples obtained from the patients regarding at least one of a) the number and/or activity of effector cells, b) the number and/or activity of regulator cells, c) molecules associated with diseases, and d) immune markers.